Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...
Novartis’ AveXis unit has said European regulators have approved its Zolgensma (onasemnogene abeparvovec) gene therapy for the rare childhood wasting disease spinal muscular atrophy (SMA), and has ...
Description: A BMI enabled version of the Sacramento Soil Moisture Accounting (Sac-SMA) model. This version of Sac-SMA allows for multiple hydrologic response units (HRUs) to be modeled at once. It ...
This integration should work with all SMA ennexOS devices. These devices are known to be compatible. Configuration is done using the UI. You'll be prompted to enter the IP and credentials to the SMA ...
Nestlé has updated the precautionary recall of several SMA Infant Formula and Follow-On Formula because they may contain cereulide toxin. The update contains amendments to the expiry dates of affected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results